$50,000 of INSULET CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"General education on diabetes care. General education about Insulet."
You can find more data on corporate lobbying on Quiver Quantitative.
PODD Insider Trading Activity
PODD insiders have traded $PODD stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $PODD stock by insiders over the last 6 months:
- ERIC BENJAMIN (EVP, CPXO) has made 0 purchases and 2 sales selling 7,264 shares for an estimated $2,376,616.
- JOHN W. KAPPLES (SVP and General Counsel) sold 5,278 shares for an estimated $1,680,884
- PREM SINGH (SVP, Global Operations) has made 0 purchases and 3 sales selling 4,357 shares for an estimated $1,366,701.
- DAN MANEA (SVP, Chief HR Officer) sold 1,300 shares for an estimated $390,065
- LAETITIA COUSIN (SVP, Reg, Quality & Compliance) sold 797 shares for an estimated $278,001
- LUCIANA BORIO sold 481 shares for an estimated $147,056
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PODD Hedge Fund Activity
We have seen 428 institutional investors add shares of PODD stock to their portfolio, and 310 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 1,340,413 shares (-22.1%) from their portfolio in Q2 2025, for an estimated $421,130,956
- CITADEL ADVISORS LLC added 627,598 shares (+436.0%) to their portfolio in Q2 2025, for an estimated $197,178,739
- MACQUARIE GROUP LTD removed 544,158 shares (-49.6%) from their portfolio in Q2 2025, for an estimated $170,963,560
- QUBE RESEARCH & TECHNOLOGIES LTD added 418,356 shares (+inf%) to their portfolio in Q2 2025, for an estimated $131,439,088
- GOLDMAN SACHS GROUP INC added 409,587 shares (+70.7%) to their portfolio in Q2 2025, for an estimated $128,684,043
- FMR LLC removed 408,984 shares (-5.2%) from their portfolio in Q2 2025, for an estimated $128,494,593
- TWO SIGMA INVESTMENTS, LP added 346,951 shares (+2105.2%) to their portfolio in Q2 2025, for an estimated $109,005,065
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PODD Analyst Ratings
Wall Street analysts have issued reports on $PODD in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 09/29/2025
- Oppenheimer issued a "Outperform" rating on 09/08/2025
- Wells Fargo issued a "Overweight" rating on 08/08/2025
- RBC Capital issued a "Outperform" rating on 08/08/2025
- Truist Securities issued a "Buy" rating on 06/16/2025
- Goldman Sachs issued a "Buy" rating on 05/30/2025
- Raymond James issued a "Outperform" rating on 05/27/2025
To track analyst ratings and price targets for PODD, check out Quiver Quantitative's $PODD forecast page.
PODD Price Targets
Multiple analysts have issued price targets for $PODD recently. We have seen 10 analysts offer price targets for $PODD in the last 6 months, with a median target of $362.5.
Here are some recent targets:
- William Plovanic from Canaccord Genuity set a target price of $399.0 on 09/29/2025
- Steven Lichtman from Oppenheimer set a target price of $365.0 on 09/08/2025
- Matt Miksic from Barclays set a target price of $300.0 on 08/21/2025
- Lawrence Biegelsen from Wells Fargo set a target price of $350.0 on 08/08/2025
- Shagun Singh from RBC Capital set a target price of $350.0 on 08/08/2025
- Richard Newitter from Truist Securities set a target price of $365.0 on 06/16/2025
- David Roman from Goldman Sachs set a target price of $380.0 on 05/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
